The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis
Abstract
Classical paraneoplastic encephalitis syndromes with 'onconeural' antibodies directed to intracellular antigens, and the recently described paraneoplastic or non-paraneoplastic encephalitides and antibodies against both neural surface antigens (voltage-gated potassium channel-complexes, N-methyl-d-aspartate receptors) and intracellular antigens (glutamic acid decarboxylase-65), constitute an increasingly recognized group of immune-mediated brain diseases. Evidence for specific immune mechanisms, however, is scarce. Here, we report qualitative and quantitative immunopathology in brain tissue (biopsy or autopsy material) of 17 cases with encephalitis and antibodies to either intracellular (Hu, Ma2, glutamic acid decarboxylase) or surface antigenic targets (voltage-gated potassium channel-complex or N-methyl-d-aspartate receptors). We hypothesized that the encephalitides with antibodies against intracellular antigens (intracellular antigen-onconeural and intracellular antigen-glutamic acid decarboxylase groups) would show neurodegeneration mediated by T cell cytotoxicity and the encephalitides with antibodies against surface antigens would be antibody-mediated and would show less T cell involvement. We found a higher CD8/CD3 ratio and more frequent appositions of granzyme-B(+) cytotoxic T cells to neurons, with associated neuronal loss, in the intracellular antigen-onconeural group (anti-Hu and anti-Ma2 cases) compared to the patients with surface antigens (anti-N-methyl-d-aspartate receptors and anti-voltage-gated potassium channel complex cases). One of the glutamic acid decarboxylase antibody encephalitis cases (intracellular antigen-glutamic acid decarboxylase group) showed multiple appositions of GrB-positive T cells to neurons. Generally, however, the glutamic acid decarboxylase antibody cases showed less intense inflammation and also had relatively low CD8/CD3 ratios compared with the intracellular antigen-onconeural cases. Conversely, we found complement C9neo deposition on neurons associated with acute neuronal cell death in the surface antigen group only, specifically in the voltage-gated potassium channel-complex antibody patients. N-methyl-d-aspartate receptors-antibody cases showed no evidence of antibody and complement-mediated tissue injury and were distinguished from all other encephalitides by the absence of clear neuronal pathology and a low density of inflammatory cells. Although tissue samples varied in location and in the stage of disease, our findings strongly support a central role for T cell-mediated neuronal cytotoxicity in encephalitides with antibodies against intracellular antigens. In voltage-gated potassium channel-complex encephalitis, a subset of the surface antigen antibody encephalitides, an antibody- and complement-mediated immune response appears to be responsible for neuronal loss and cerebral atrophy; the apparent absence of these mechanisms in N-methyl-d-aspartate receptors antibody encephalitis is intriguing and requires further study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
Dalmau, J., Gleichman, A. J., Hughes, E. G., Rossi, J. E., Peng, X., Lai, M., Dessain, S. K., Rosenfeld, M. R., Balice-Gordon, R., & Lynch, D. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70224-2 · Cited by 3,488
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
Dalmau, J., Lancaster, E., Martinez-Hernandez, E., Rosenfeld, M. R., & Balice-Gordon, R. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70253-2 · Cited by 2,435
Betts, M. R., Brenchley, J. M., Price, D. A., De Rosa, S. C., Douek, D. C., Roederer, M., & Koup, R. A. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(03)00265-5 · Cited by 1,587
Lai, M., Huijbers, M. G., Lancaster, E., Graus, F., Bataller, L., Balice-Gordon, R., Cowell, J. K., & Dalmau, J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70137-x · Cited by 1,361
Self-citationIrani, S. R., Alexander, S., Waters, P., Kleopa, K. A., Pettingill, P., Zuliani, L., Peles, E., Buckley, C., Lang, B., & Vincent, A. (2010) · Brain · doi:10.1093/brain/awq213 · Cited by 1,359
Self-citationCellular and synaptic mechanisms of anti-NMDA receptor encephalitis
Hughes, E. G., Peng, X., Gleichman, A. J., Lai, M., Zhou, L., Tsou, R., Parsons, T. D., Lynch, D. R., Dalmau, J., & Balice-Gordon, R. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0167-10.2010 · Cited by 1,143
Vincent, A., Buckley, C., Schott, J. M., Baker, I., Dewar, B., Detert, N., Clover, L., Parkinson, A., Bien, C. G., Omer, S., et al. (2004) · Brain · doi:10.1093/brain/awh077 · Cited by 1,038
Self-citationIrani, S. R., Bera, K., Waters, P., Zuliani, L., Maxwell, S., Zandi, M. S., Friese, M. A., Galea, I., Kullmann, D. M., Beeson, D., et al. (2010) · Brain · doi:10.1093/brain/awq113 · Cited by 1,035
Self-citationLancaster, E., Lai, M., Peng, X., Hughes, E., Constantinescu, R., Raizer, J., Friedman, D., Skeen, M. B., Grisold, W., Kimura, A., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70324-2 · Cited by 928
Self-citationAnti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients
Graus, F. (2001) · Brain · doi:10.1093/brain/124.6.1138 · Cited by 897
Self-citationParaneoplastic syndromes of the CNS
Dalmau, J., & Rosenfeld, M. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70060-7 · Cited by 873
AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location
Lai, M., Hughes, E. G., Peng, X., Zhou, L., Gleichman, A. J., Shu, H., Matà, S., Kremens, D., Vitaliani, R., Geschwind, M. D., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21589 · Cited by 813
Self-citationMesial Temporal Lobe Epilepsy with Hippocampal Sclerosis
Compiled by Heinz‐Gregor Wieser for the ILAE Commission on Neurosurgery of Epilepsy (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.09004.x · Cited by 773
Arahata, K., & Engel, A. G. (1984) · Annals of Neurology · doi:10.1002/ana.410160206 · Cited by 630
Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis
Malter, M. P., Helmstaedter, C., Urbach, H., Vincent, A., & Bien, C. G. (2010) · Annals of Neurology · doi:10.1002/ana.21917 · Cited by 514
Self-citationLimbic Encephalitis and Variants: Classification, Diagnosis and Treatment
Tüzün, E., & Dalmau, J. (2007) · The Neurologist · doi:10.1097/nrl.0b013e31813e34a5 · Cited by 478
High-Dose Intravenous Immune Globulin for Stiff-Person Syndrome
Dalakas, M. C., Fujii, M., Li, M., Lutfi, B., Kyhos, J., & McElroy, B. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa01167 · Cited by 434
Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody
Thieben, M. J., Lennon, V. A., Boeve, B. F., Aksamit, A. J., Keegan, M., & Vernino, S. (2004) · Neurology · doi:10.1212/01.wnl.0000122648.19196.02 · Cited by 394
Antibodies and neuronal autoimmune disorders of the CNS
Graus, F., Saiz, A., & Dalmau, J. (2010) · Journal of Neurology · doi:10.1007/s00415-009-5431-9 · Cited by 392
Self-citationDestruction of neurons by cytotoxic T cells: A new pathogenic mechanism in rasmussen's encephalitis
Bien, C. G., Bauer, J., Deckwerth, T. L., Wiendl, H., Deckert, M., Wiestler, O. D., Schramm, J., Elger, C. E., & Lassmann, H. (2002) · Annals of Neurology · doi:10.1002/ana.10100 · Cited by 364
Self-citationTüzün, E., Zhou, L., Baehring, J. M., Bannykh, S., Rosenfeld, M. R., & Dalmau, J. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0582-4 · Cited by 360
Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome
Lancaster, E., Martinez-Hernandez, E., Titulaer, M. J., Boulos, M., Weaver, S., Antoine, J.-C., Liebers, E., Kornblum, C., Bien, C. G., Honnorat, J., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e3182364a44 · Cited by 359
Self-citationGABA B receptor antibodies in limbic encephalitis and anti-GAD–associated neurologic disorders
Boronat, A., Sabater, L., Saiz, A., Dalmau, J., & Graus, F. (2011) · Neurology · doi:10.1212/wnl.0b013e31820e7b8d · Cited by 271
Self-citationStam, N. J., Vroom, T. M., Peters, P. J., Pastoors, E. B., & Ploegh, H. L. (1990) · International Immunology · doi:10.1093/intimm/2.2.113 · Cited by 250
Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy
Bien, C. G., Urbach, H., Schramm, J., Soeder, B. M., Becker, A. J., Voltz, R., Vincent, A., & Elger, C. E. (2007) · Neurology · doi:10.1212/01.wnl.0000276946.08412.ef · Cited by 235
Self-citationDiagnostic Value of N-methyl-D-aspartate Receptor Antibodies in Women With New-Onset Epilepsy
Niehusmann, P., Dalmau, J., Rudlowski, C., Vincent, A., Elger, C. E., Rossi, J. E., & Bien, C. G. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.5 · Cited by 180
Self-citationCytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes.
Panina-Bordignon, P., Lang, R., van Endert, P. M., Benazzi, E., Felix, A. M., Pastore, R. M., Spinas, G. A., & Sinigaglia, F. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1923 · Cited by 172
Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis
Bernal, F., Graus, F., Pifarré, À., Saiz, A., Benyahia, B., & Ribalta, T. (2002) · Acta Neuropathologica · doi:10.1007/s00401-001-0498-0 · Cited by 171
Self-citationGAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes
Viglietta, V., Kent, S. C., Orban, T., & Hafler, D. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14114 · Cited by 170
Astrocytes are a specific immunological target in Rasmussen's encephalitis
Bauer, J., Elger, C. E., Hans, V. H., Schramm, J., Urbach, H., Lassmann, H., & Bien, C. G. (2007) · Annals of Neurology · doi:10.1002/ana.21148 · Cited by 165
Self-citationCD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery
Schwab, N., Bien, C. G., Waschbisch, A., Becker, A., Vince, G. H., Dornmair, K., & Wiendl, H. (2009) · Brain · doi:10.1093/brain/awp003 · Cited by 165
Self-citationJean, W. C., Dalmau, J. O., Ho, A., & Posner, J. B. (1994) · Neurology · doi:10.1212/wnl.44.1.140 · Cited by 155
Immunoglobulins and complement in postmortem multiple sclerosis tissue
Barnett, M. H., Parratt, J. D. E., Cho, E., & Prineas, J. W. (2009) · Annals of Neurology · doi:10.1002/ana.21524 · Cited by 152
Self-citationReversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study
Iizuka, T., Yoshii, S., Kan, S., Hamada, J., Dalmau, J. O., Sakai, F., & Mochizuki, H. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5604-6 · Cited by 116
Vincent, A. C., Irani, S. R., & Lang, B. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32833735fe · Cited by 115
Self-citationBrain immunohistopathological study in a patient with anti-NMDAR encephalitis
Camdessanché, J., Streichenberger, N., Cavillon, G., Rogemond, V., Jousserand, G., Honnorat, J., Convers, P., & Antoine, J.-C. G. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03180.x · Cited by 113
Buckley, C. J., & Vincent, A. C. (2005) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0033 · Cited by 70
Self-citationParaneoplastic brain stem encephalitis in a woman with anti-Ma2 antibody
Barnett, M. H. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.2.222 · Cited by 67
Self-citationHISTOPATHOLOGY OF VGKC ANTIBODY–ASSOCIATED LIMBIC ENCEPHALITIS
Khan, N. L., Jeffree, M. A., Good, C. D., Macleod, W., & Al‐Sarraj, S. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a55eb3 · Cited by 65
Early pathologic findings and long-term improvement in anti-Ma2–associated encephalitis
Blumenthal, D. T., Salzman, K. L., Digre, K. B., Jensen, R. L., Dunson, W. A., & Dalmau, J. O. (2006) · Neurology · doi:10.1212/01.wnl.0000223647.83708.20 · Cited by 62
Pathogenic autoantibodies to neuronal proteins in neurological disorders
Vincent, A. C., Lily, O., & Palace, J. A. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00210-6 · Cited by 45
Self-citationAntigen Presentation and Cytotoxic T Lymphocyte Killing Studied in Individual, Living Cells
Hahn, K. M., DeBiasio, R. L., Tishon, A., Lewicki, H. A., Gairin, J. E., LaRocca, G., Taylor, D. L., & Oldstone, M. B. A. (1994) · Virology · doi:10.1006/viro.1994.1298 · Cited by 19
GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes
Viglietta, V., Kent, S. C., Orban, T., & Hafler, D. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214114 · Cited by 16
Cited by
Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy
Vezzani, A., Balosso, S., & Ravizza, T. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0217-x · Cited by 893
Immunoneuropsychiatry — novel perspectives on brain disorders
Pape, K., Tamouza, R., Leboyer, M., & Zipp, F. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0174-4 · Cited by 458
Irani, S. R., Stagg, C. J., Schott, J. M., Rosenthal, C. R., Schneider, S. A., Pettingill, P., Pettingill, R., Waters, P., Thomas, A., Voets, N. L., et al. (2013) · Brain · doi:10.1093/brain/awt212 · Cited by 437
Self-citationAntibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders
Dale, R. C., Merheb, V., Pillai, S., Wang, D., Cantrill, L., Murphy, T. K., Ben-Pazi, H., Varadkar, S., Aumann, T. D., Horne, M. K., et al. (2012) · Brain · doi:10.1093/brain/aws256 · Cited by 388
Autoantibodies in neurological disease
Prüss, H. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00543-w · Cited by 319
Metadata
- Authors
- Bien, C. G., Vincent, A., Barnett, M. H., Becker, A. J., Blumcke, I., Graus, F., Jellinger, K. A., Reuss, D. E., Ribalta, T., Schlegel, J., Sutton, I., Lassmann, H., & Bauer, J.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-04-25
- Volume
- 135
- Issue
- 5
- Pages
- 1622-1638
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2028332032
- Cited by
- 695
- References
- 43
- FWCI
- 26.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.